Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis

Giuseppe Gritti, MD, Augusto B Federici, MD, Agostino Cortelezzi, MD, Luciano Baronciani, PhD, Silvia Lonati, PhD, Margherita Punzo, Ilaria Silvestris, Rosanna Garavaglia, MD, Giorgio Lambertenghi, MD, Pier M Mannucci, MD

Blood (2008) 112 (11): 5457.

https://doi.org/10.1182/blood.V112.11.5457.5457

Published: 2008

Journal Articles

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Luciano Baronciani, PhD, Flora Peyvandi, MD, Margherita Punzo, PhD, Maria T. Canciani, PhD, Enrico Di Stasio, MD, Augusto B. Federici, MD, Pier M. Mannucci, MD, Raimondo De Cristofaro, MD

Blood (2008) 112 (11): 3384.

https://doi.org/10.1182/blood.V112.11.3384.3384

Published: 2008

Journal Articles

Type 2B “Malmo/New York” Is Not So Rare among Italian Patients with von Willebrand Disease: The Role of P1266L/Q Mutations of the von Willebrand Factor Gene in Seven Cases.

Luciano Baronciani, PhD, Silvia La Marca, PhD, Giancarlo Castaman, MD, Margherita Punzo, PhD, Rosanna Garavaglia, MD, Valentina Rubini, PhD, Giovanna Cozzi, PhD, Maria T. Canciani, PhD, Augusto B. Federici, MD

Blood (2007) 110 (11): 712.

https://doi.org/10.1182/blood.V110.11.712.712

Published: 2007

Journal Articles

Molecular Mapping of the Chloride Binding Site in von Willebrand Factor (VWF): Energetics and Conformational Effects on the ADAMTS-13 Interaction with Wild Type and Type 2B R1306W VWF Forms.

Raimondo De Cristofaro, MD, Flora Peyvandi, MD, Luciano Baronciani, PhD, Roberta Palla, PhD, Silvia Lavoretano, PhD, Rossana Lombardi, PhD, Enrico Di Stasio, MD, Augusto B. Federici, MD, Pier Mannuccio Mannucci, MD

Blood (2006) 108 (11): 333.

https://doi.org/10.1182/blood.V108.11.333.333

Published: 2006

Journal Articles

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Augusto B. Federici, MD, Luciano Baronciani, PhD, Maria T. Canciani, PhD, Barbara Moroni, PhD, Carlo Balduini, MD, Pier M. Mannucci, MD, Peter J. Lenting, PhD, Philip G. de Groot, PhD

Blood (2006) 108 (11): 1011.

https://doi.org/10.1182/blood.V108.11.1011.1011

Published: 2006

Journal Articles

Biochemical Characterization of Recombinant Von Willebrand Factor (VWF) with a Type 2B Mutation (P1337L) Coexpressed with a Type 1 VWF Defect (C275R): A Complex Molecular Defect in a Patient Previously Diagnosed with Type 2A Von Willebrand Disease (VWD).

Luciano Baronciani, PhD, Augusto B. Federici, MD, Matteo Beretta, PhD, Giovanna Cozzi, PhD, Maria T. Canciani, PhD, Pier M. Mannucci, MD

Blood (2004) 104 (11): 1025.

https://doi.org/10.1182/blood.V104.11.1025.1025

Published: 2004

NARROW

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis

Relevance of Chloride Binding to Von Willebrand Factor in Type 2B Von Willebrand Disease Patients.

Type 2B “Malmo/New York” Is Not So Rare among Italian Patients with von Willebrand Disease: The Role of P1266L/Q Mutations of the von Willebrand Factor Gene in Seven Cases.

Molecular Mapping of the Chloride Binding Site in von Willebrand Factor (VWF): Energetics and Conformational Effects on the ADAMTS-13 Interaction with Wild Type and Type 2B R1306W VWF Forms.

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Biochemical Characterization of Recombinant Von Willebrand Factor (VWF) with a Type 2B Mutation (P1337L) Coexpressed with a Type 1 VWF Defect (C275R): A Complex Molecular Defect in a Patient Previously Diagnosed with Type 2A Von Willebrand Disease (VWD).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only